PROF · NASDAQ
Profound Medical (PROF) Stock Price & Fundamentals
Profound Medical (PROF) closed at $260.26 on Oct 9, 2026, up 0.45% from the previous close of $259.10.
Share price, past year
1Y +8.02%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $260.26 |
| Sep 30, 2026 | $254.97 |
| Aug 31, 2026 | $256.86 |
| Jul 31, 2026 | $239.43 |
| Jun 30, 2026 | $239.20 |
| May 29, 2026 | $240.31 |
| Apr 30, 2026 | $233.94 |
| Mar 31, 2026 | $241.12 |
| Feb 27, 2026 | $250.91 |
| Jan 30, 2026 | $249.38 |
| Dec 31, 2025 | $250.93 |
| Nov 28, 2025 | $240.02 |
| Oct 31, 2025 | $235.42 |
Key statistics
- Market cap
- $9.51B
- P/E (TTM)
- 173.5
- EPS (TTM)
- $1.50
- Revenue (TTM)
- $19.09M
- Net income (TTM)
- −$32.74M
- Shares outstanding
- 36.5M
- Dividend yield
- —
- 52-week range
- $229.17 – $263.57
Profound Medical's market cap is $9.51B, based on a share price of $260.26 and 36.5M shares outstanding as of Jun 30, 2026.
Financials
Profound Medical reported revenue of $16.10M for fiscal 2025, up 50.73% from fiscal 2024.
Profound Medical reported a net loss of $42.57M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $16.10M | +50.7% | −$42.57M | −264.4% | $1.41 | −$38.38M |
| FY2024ended Dec 31, 2024 | $10.68M | +48.4% | −$27.82M | −260.5% | $1.12 | — |
| FY2023ended Dec 31, 2023 | $7.20M | — | −$28.32M | −393.4% | $1.34 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $2.48M | −$9.54M | −$0.26 |
| Q1 FY2026ended Mar 31, 2026 | $5.34M | −$7.05M | $0.19 |
| Q4 FY2025ended Dec 31, 2025 | $5.98M | −$8.17M | $1.31 |
| Q3 FY2025ended Sep 30, 2025 | $5.29M | −$7.98M | $0.26 |
| Q2 FY2025ended Jun 30, 2025 | $2.21M | −$15.70M | −$0.52 |
| Q1 FY2025ended Mar 31, 2025 | $2.62M | −$10.72M | $0.36 |
| Q4 FY2024ended Dec 31, 2024 | $4.18M | −$4.95M | $0.19 |
| Q3 FY2024ended Sep 30, 2024 | $2.83M | −$9.37M | $0.38 |
Company profile
- Name
- Profound Medical Corp.
- Ticker
- PROF
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 2400 Skymark Avenue, Unit 6, Mississauga, A6 L4W 5K5
- Incorporated in
- A6
- Fiscal year ends
- December
- SEC CIK
- 0001628808
Recent SEC filings
- Oct 7, 2026
- Sep 4, 2026
- Sep 3, 2026
- Aug 17, 2026
- Aug 17, 2026
- Aug 13, 2026
- Aug 6, 2026
- Aug 6, 2026
Frequently asked questions
What is Profound Medical's stock price?
Profound Medical (PROF) closed at $260.26 on Oct 9, 2026, up 0.45% from the previous close of $259.10.
What is Profound Medical's market cap?
Profound Medical's market cap is $9.51B, based on a share price of $260.26 and 36.5M shares outstanding as of Jun 30, 2026.
How much revenue does Profound Medical make?
Profound Medical reported revenue of $16.10M for fiscal 2025, up 50.73% from fiscal 2024.
What is PROF's P/E ratio?
Profound Medical's price-to-earnings ratio is 173.5, based on trailing twelve-month diluted EPS of $1.50.
Does Profound Medical pay a dividend?
Profound Medical's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Profound Medical Corp.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures